Maravai LifeSciencesMRVI
那斯達克 · USD
2.22
-0.12
(-5.13%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Maravai LifeSciencesMRVI
2.22
-0.12
(-5.13%)
財務數據
損益表
- 2.05
- 0.79
- 0.69
- 0.67
- 0.74
- 0.64
- 0.73
- 0.65
- 0.56
- 0.47
- 7.03
- -61.40
- -12.79
- -2.97
- 10.88
- -13.44
- 14.37
- -11.17
- -13.49
- -16.94
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 46,850 | 56,406 | 65,200 | 73,400 | 64,179 | 74,141 | 66,865 | 68,914 | 79,025 | 204,713 |
營業成本 | 39,125 | 37,444 | 36,826 | 38,271 | 38,335 | 35,108 | 36,686 | 43,273 | 33,676 | 53,253 |
營業毛利 | 7,725 | 18,962 | 28,374 | 35,129 | 25,844 | 39,033 | 30,179 | 25,641 | 45,349 | 151,460 |
營業費用 | 56,887 | 57,092 | 197,488 | 44,641 | 44,705 | 46,183 | 45,596 | 37,255 | 42,816 | 42,214 |
研發費用 | 4,888 | 4,561 | 4,344 | 5,284 | 5,032 | 4,594 | 4,347 | 4,194 | 4,145 | 5,011 |
推銷及管理費用 | 39,564 | 40,613 | 38,909 | 39,361 | 40,885 | 35,123 | 41,249 | 33,061 | 38,671 | 37,203 |
非經常性項目費用 | 12,435 | 11,918 | 154,235 | -4 | -1,212 | 6,466 | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -49,162 | -38,130 | -169,114 | -9,512 | -18,861 | -7,150 | -15,417 | -11,614 | 2,533 | 109,246 |
其他收入及費用 | 3,249 | 2,891 | 7,104 | 4,524 | 7,316 | 678,736 | 6,491 | 5,272 | 4,777 | -3,190 |
利息費用 | 6,778 | 11,263 | 13,634 | 11,939 | 10,864 | 15,400 | 11,637 | 7,022 | 11,833 | 10,180 |
稅前純益 | -52,691 | -46,502 | -175,644 | -16,927 | -22,409 | 656,186 | -20,563 | -13,364 | -4,523 | 95,876 |
所得稅 | 162 | -7 | 311 | -2,435 | 271 | 766,168 | -5,461 | -1,421 | -3,175 | 8,447 |
稅後純益 | -29,945 | -26,145 | -99,038 | -7,585 | -12,078 | -105,959 | -6,462 | -6,541 | -67 | 37,634 |
基本每股稅後盈餘(元) | -0.21 | -0.18 | -0.70 | -0.05 | -0.09 | -0.80 | -0.05 | -0.05 | 0.00 | 0.28 |
稀釋每股稅後盈餘(元) | -0.21 | -0.18 | -0.72 | -0.06 | -0.09 | -0.80 | -0.05 | -0.05 | 0.00 | 0.30 |
基本平均股數(千股) | 143425.00 | 141812.00 | 141555.00 | 135842.00 | 132333.00 | 132140.00 | 131930.00 | 131864.00 | 131739.00 | 131627.00 |
稀釋平均股數(千股) | 143425.00 | 141812.00 | 141555.00 | 135842.00 | 132333.00 | 132140.00 | 131930.00 | 131864.00 | 131739.00 | 131651.00 |
還原基本每股稅後盈餘(元) | -0.21 | -0.18 | -0.70 | -0.05 | -0.09 | -0.80 | -0.05 | -0.05 | 0.00 | 0.28 |
還原稀釋每股稅後盈餘(元) | -0.21 | -0.18 | -0.72 | -0.06 | -0.09 | -0.80 | -0.05 | -0.05 | 0.00 | 0.30 |
還原基本平均股數(千股) | 143,425 | 141,812 | 141,555 | 135,842 | 132,333 | 132,140 | 131,930 | 131,864 | 131,739 | 131,627 |
還原稀釋平均股數(千股) | 143,425 | 141,812 | 141,555 | 135,842 | 132,333 | 132,140 | 131,930 | 131,864 | 131,739 | 131,651 |
EBITDA(千元) | -7,634 | 295 | -70,300 | 17,210 | 13,550 | 689,332 | 13,548 | 11,587 | 20,217 | 66,944 |